- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Cancer with CRISPR/Cas9-Based Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 1, Pages 573
Publisher
MDPI AG
Online
2022-01-07
DOI
10.3390/ijms23010573
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis
- (2021) Julia O. Misiorek et al. Cells
- CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research
- (2021) Yue Yang et al. Frontiers in Medicine
- Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing
- (2021) Xingang Yao et al. Journal of Extracellular Vesicles
- Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles
- (2021) Jing Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- Regulatory Mechanism of MicroRNA Expression in Cancer
- (2020) Zainab Ali Syeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Programmable base editing of mutated TERT promoter inhibits brain tumour growth
- (2020) Xinjian Li et al. NATURE CELL BIOLOGY
- Recent advances of oncolytic virus in cancer therapy
- (2020) Moumita Mondal et al. Human Vaccines & Immunotherapeutics
- Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
- (2020) You Lu et al. NATURE MEDICINE
- Regulation of human telomerase in homeostasis and disease
- (2020) Caitlin M. Roake et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Recent Advances in CRISPR/Cas9 Delivery Strategies
- (2020) Bon Ham Yip Biomolecules
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- First Trial of CRISPR-Edited T cells in Lung Cancer
- (2020) Simon F. Lacey et al. TRENDS IN MOLECULAR MEDICINE
- Prime Editing: Genome Editing for Rare Genetic Diseases Without Double-Strand Breaks or Donor DNA
- (2020) Ianis G. Matsoukas Frontiers in Genetics
- Engineering a far-red light–activated split-Cas9 system for remote-controlled genome editing of internal organs and tumors
- (2020) Yuanhuan Yu et al. Science Advances
- Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects
- (2020) Shaohui Deng et al. Science Advances
- CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi’s sarcoma-associated herpesvirus
- (2020) Zhipin Liang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tropism-facilitated delivery of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies
- (2020) Qian Xu et al. JOURNAL OF CONTROLLED RELEASE
- Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
- (2020) Win Topatana et al. Journal of Hematology & Oncology
- CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
- (2020) Mohammadreza Azangou-Khyavy et al. Frontiers in Immunology
- CRISPR technology: The engine that drives cancer therapy
- (2020) Mingtao Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions
- (2020) Abu Hazafa et al. LIFE SCIENCES
- Controlling and enhancing CRISPR systems
- (2020) Haridha Shivram et al. Nature Chemical Biology
- CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1
- (2020) Amanda R. Panfil et al. Frontiers in Cellular and Infection Microbiology
- CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
- (2019) Benjamin L. Oakes et al. CELL
- Reduction of Kaposi's sarcoma-associated herpesvirus latency using CRISPR-Cas9 to edit the latency-associated nuclear antigen gene
- (2019) For Yue Tso et al. JOURNAL OF VIROLOGY
- CRISPR/Cas9 for overcoming drug resistance in solid tumors
- (2019) Ali Saber et al. DARU-Journal of Pharmaceutical Sciences
- Cancer therapy with a CRISPR-assisted telomerase-activating gene expression system
- (2019) Wei Dai et al. ONCOGENE
- CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
- (2019) Bin Liu et al. DRUG DISCOVERY TODAY
- CRISPR-Cas9 for cancer therapy: Opportunities and challenges
- (2019) Minjiang Chen et al. CANCER LETTERS
- Telomerase-Targeted Cancer Immunotherapy
- (2019) Eishiro Mizukoshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
- (2019) Mareike D Hoffmann et al. NUCLEIC ACIDS RESEARCH
- Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer
- (2019) Katherine Redd Bowman et al. Journal of Ovarian Research
- Delivery of CRISPR/Cas9 for therapeutic genome editing
- (2019) Xiaojie Xu et al. JOURNAL OF GENE MEDICINE
- Improving homology-directed repair efficiency in human stem cells
- (2019) William C. Skarnes et al. METHODS
- Improved double-nicking strategies for COL7A1 editing by homologous recombination
- (2019) Thomas Kocher et al. Molecular Therapy-Nucleic Acids
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Synthetic lethality as an engine for cancer drug target discovery
- (2019) Alan Huang et al. NATURE REVIEWS DRUG DISCOVERY
- CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
- (2019) Haifeng Huo et al. Infectious Agents and Cancer
- CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells
- (2019) Joanna Jacków et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
- (2019) Fengqian Chen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy
- (2018) Hong-yan Wu et al. Briefings in Functional Genomics
- Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus
- (2018) Ioannis Gavvovidis et al. CLINICAL CANCER RESEARCH
- Hallmarks of cancer: The CRISPR generation
- (2018) Colette Moses et al. EUROPEAN JOURNAL OF CANCER
- Targeting HPV16 DNA using CRISPR/Cas inhibits anal cancer growth in vivo
- (2018) David S Hsu et al. Future Virology
- Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9
- (2018) Alvin Ho-Kwan Cheung et al. LABORATORY INVESTIGATION
- CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors
- (2018) Clemens Reinshagen et al. Science Translational Medicine
- CRISPR/Cas9 for cancer research and therapy
- (2018) Tianzuo Zhan et al. SEMINARS IN CANCER BIOLOGY
- Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins
- (2018) Alexander P. Hynes et al. Nature Communications
- A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
- (2018) Jonathan D. Finn et al. Cell Reports
- CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
- (2018) Hasan Mollanoori et al. HUMAN IMMUNOLOGY
- Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
- (2018) Johnny H. Hu et al. NATURE
- Oncolytic virus-mediated RAS targeting in rhabdomyosarcoma
- (2018) Michael P. Phelps et al. Molecular Therapy-Oncolytics
- Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy
- (2018) Le Wang et al. CHEMBIOCHEM
- Oncolytic virus immunotherapy: future prospects for oncology
- (2018) Junaid Raja et al. Journal for ImmunoTherapy of Cancer
- Engineering liposomal nanoparticles for targeted gene therapy
- (2017) C Zylberberg et al. GENE THERAPY
- Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
- (2017) Chang Liu et al. JOURNAL OF CONTROLLED RELEASE
- Type II CRISPR/Cas9 approach in the oncological therapy
- (2017) A. Biagioni et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene
- (2017) Zhang-Hui Chen et al. NATURE BIOTECHNOLOGY
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Cell-type-specific genome editing with a microRNA-responsive CRISPR–Cas9 switch
- (2017) Moe Hirosawa et al. NUCLEIC ACIDS RESEARCH
- CRISPR/Cas9-mediated noncoding RNA editing in human cancers
- (2017) Jie Yang et al. RNA Biology
- In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
- (2017) Eunji Kim et al. Nature Communications
- Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC
- (2017) Deborah Y. Kwon et al. Nature Communications
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth
- (2016) Lifeng Yang et al. Cell Metabolism
- Reactivation of telomerase in cancer
- (2016) Semih Can Akincilar et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Exploring miRNA based approaches in cancer diagnostics and therapeutics
- (2016) Shivangi Mishra et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cancer-specific promoters for expression-targeted gene therapy:ran,brms1andmcm5
- (2016) Xuguang Chen et al. JOURNAL OF GENE MEDICINE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome
- (2016) Shuai Zhen et al. Oncotarget
- CRISPR/Cas9 and cancer targets: future possibilities and present challenges
- (2016) Martyn K. White et al. Oncotarget
- Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids
- (2016) Kyle Chamberlain et al. Human Gene Therapy Methods
- Driver and Passenger Mutations in Cancer
- (2015) Julia R. Pon et al. Annual Review of Pathology-Mechanisms of Disease
- Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
- (2015) Chunsheng Dong et al. ANTIVIRAL RESEARCH
- Tissue Specific Promoters in Colorectal Cancer
- (2015) A. R. Rama et al. DISEASE MARKERS
- CRISPR/Cas9-Mediated Genome Editing of Epigenetic Factors for Cancer Therapy
- (2015) Shaohua Yao et al. HUMAN GENE THERAPY
- Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
- (2015) Xing Liu et al. JOURNAL OF GENERAL VIROLOGY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Cas9-mediated targeting of viral RNA in eukaryotic cells
- (2015) Aryn A. Price et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9
- (2014) Shuai Zhen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- KRAS mutation testing in clinical practice
- (2014) Sudhir Perincheri et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells
- (2014) K.-S. Yuen et al. JOURNAL OF GENERAL VIROLOGY
- Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease
- (2014) E. M. Kennedy et al. JOURNAL OF VIROLOGY
- Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells
- (2014) Yuchen Liu et al. Nature Communications
- Cancer heterogeneity: implications for targeted therapeutics
- (2013) R Fisher et al. BRITISH JOURNAL OF CANCER
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Telomerase: Structure, functions, and activity regulation
- (2011) M. I. Zvereva et al. BIOCHEMISTRY-MOSCOW
- Tumor-Targeted Drug Delivery with Aptamers
- (2011) Y. Zhang et al. CURRENT MEDICINAL CHEMISTRY
- Cell-Specific Aptamer-Mediated Targeted Drug Delivery
- (2010) Jiehua Zhou et al. OLIGONUCLEOTIDES
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started